Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.


Journal

Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 30 10 2018
medline: 3 3 2020
entrez: 30 10 2018
Statut: ppublish

Résumé

The assessment of individuals from families affected by familial frontotemporal dementia (FTD) allows the evaluation of preclinical or pre-diagnosis disease markers. The current work aims to investigate the existence of a cognitive phase in GRN mutation carriers before overt clinical symptoms begin. We performed a longitudinal neuropsychological analysis (three assessments in 4 years) in a group of presymptomatic c.709-1G>A progranulin (GRN) (n=15) mutation carriers and non-carrier relatives (n=25) from seven FTD families. GRN mutation carriers showed subtle decline over the longitudinal follow-up in several different domains (namely, attention, facial affect recognition, decision-making, language, and memory). The differences between groups were most marked in the facial affect recognition test, with improvement in the non-carrier group and decline in the GRN mutation carrier group, with very large effect sizes. Facial affect recognition may decline before clinical diagnosis and makes the adapted version of the Picture of Facial Affect a potential candidate for early detection of GRN-associated FTD. (JINS, 2019, 25, 39-47).

Identifiants

pubmed: 30369339
pii: S1355617718000735
doi: 10.1017/S1355617718000735
doi:

Substances chimiques

Biomarkers 0
GRN protein, human 0
Progranulins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-47

Auteurs

Myriam Barandiaran (M)

1Cognitive Disorders Unit,Department of Neurology,Donostia University Hospital,Paseo Dr Begiristain sn,CP 20014,San Sebastian,Gipuzkoa,Spain.

Fermín Moreno (F)

1Cognitive Disorders Unit,Department of Neurology,Donostia University Hospital,Paseo Dr Begiristain sn,CP 20014,San Sebastian,Gipuzkoa,Spain.

María de Arriba (M)

1Cognitive Disorders Unit,Department of Neurology,Donostia University Hospital,Paseo Dr Begiristain sn,CP 20014,San Sebastian,Gipuzkoa,Spain.

Begoña Indakoetxea (B)

1Cognitive Disorders Unit,Department of Neurology,Donostia University Hospital,Paseo Dr Begiristain sn,CP 20014,San Sebastian,Gipuzkoa,Spain.

Irati Boda (I)

4Department of Computer Science,Multimedia and Telecommunications,Universitat Oberta de Catalunya,Barcelona,Spain.

Alazne Gabilondo (A)

2Center for Networked Biomedical Research on Neurodegenerative Disease (CIBERNED),area 6,Carlos III Health Institute,Spain.

Mikel Tainta (M)

2Center for Networked Biomedical Research on Neurodegenerative Disease (CIBERNED),area 6,Carlos III Health Institute,Spain.

Adolfo López de Munain (A)

1Cognitive Disorders Unit,Department of Neurology,Donostia University Hospital,Paseo Dr Begiristain sn,CP 20014,San Sebastian,Gipuzkoa,Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH